Husaric Senada, Salihovic Azra Avdic, Kadric Nedzad, Iljazovic-Topic Samra, Pasic Jasmina, Divanovic Anida
Health Institution, Special Hospital "Medical Institute Bayer" MIB, Tuzla, Bosnia and Herzegovina.
Internal Clinic, University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina.
Mater Sociomed. 2023 Mar;35(1):13-17. doi: 10.5455/msm.2023.35.13-17.
Medical nutritional therapy (MNT) is a key component in the treatment of Diabetes mellitus (DM). MNT is completely individual and should be present in the treatment of diabetes from the very beginning, continuously with pharmacological therapy, taking into account lifestyle, dietary habits and the type of antidiabetic therapy. Mistakes that are made when planning the diet are the absence of individual adjustment of the diet, which means that the number and time of meals, as well as the amount of UH per meal, is not adjusted to the patients' oral or insulin therapy according to their pharmacokinetics and pharmacodynamics.
This study investigated the effect of MNT with reduced carbohydrate content (MNT M-ADA) on the efficacy of human and analogue premix insulin in patients with T2DM.
Subjects were randomized into two groups (human and analog premix insulins), and then each group into two subgroups of 30 subjects each. One subgroup each on therapy with human and analog biphasic insulins was educated about MNT and learned to count UH, and then they applied MNT M-ADA for 24 weeks, unlike the other two subgroups. In this review, we present only the subgroup analysis on human and analog premix insulins that applied MNT M-ADA (200 g UH/day). Efficacy outcomes in the analysis of these subgroups were estimated changes in each subgroup from baseline to end point (week 24) and differences between subgroups at the end of the study in levels of glycated hemoglobin (HbA1c), self-measured glucose values (SMBG) and frequency of hypoglycemia.
Both subgroups of subjects with MNT M-ADA improved glycemic control, which was assessed by improvements in HBA1C, SMBG levels, without an increase in the frequency of hypoglycemia, but at the end of the study there was no statistically significant difference in the mentioned parameters between the subgroups.
The effectiveness of MNT M-ADA in people with T2DM did not depend on the type of insulin, both insulin regimens are effective if the amount of ingested UH is taken into account.
医学营养治疗(MNT)是糖尿病(DM)治疗的关键组成部分。MNT是完全个性化的,应从糖尿病治疗一开始就存在,并与药物治疗持续配合,同时要考虑生活方式、饮食习惯和抗糖尿病治疗类型。饮食计划中出现的错误是缺乏饮食的个体化调整,这意味着餐数和用餐时间以及每餐的碳水化合物摄入量没有根据患者的口服或胰岛素治疗的药代动力学和药效学进行调整。
本研究调查了碳水化合物含量降低的医学营养治疗(MNT M-ADA)对2型糖尿病(T2DM)患者中人类胰岛素和类似物预混胰岛素疗效的影响。
将受试者随机分为两组(人类胰岛素和类似物预混胰岛素),然后每组再分为两个亚组,每组30名受试者。使用人类和类似物双相胰岛素治疗的各一个亚组接受了MNT教育并学会计算碳水化合物量,然后他们应用MNT M-ADA 24周,另外两个亚组则不同。在本综述中,我们仅展示了应用MNT M-ADA(每日200克碳水化合物)的人类胰岛素和类似物预混胰岛素的亚组分析。这些亚组分析中的疗效结果是估计每个亚组从基线到终点(第24周)的变化以及研究结束时亚组之间糖化血红蛋白(HbA1c)水平、自我测量血糖值(SMBG)和低血糖发生频率的差异。
接受MNT M-ADA的两个亚组的受试者血糖控制均得到改善,这通过HbA1C、SMBG水平的改善来评估,且低血糖发生频率没有增加,但研究结束时,亚组之间在上述参数上没有统计学上的显著差异。
MNT M-ADA对T2DM患者的有效性不取决于胰岛素类型,如果考虑到摄入的碳水化合物量,两种胰岛素治疗方案都是有效的。